Symetryx Corp - Sep 7, 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
10%+ Owner
Signature
Barry Shiff
Stock symbol
NBSE
Transactions as of
Sep 7, 2023
Transactions value $
-$336,731
Form type
4
Date filed
9/11/2023, 05:08 PM
Previous filing
Sep 7, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$135K -74.9K -11.01% $1.80 605K Sep 7, 2023 Direct F1
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$197K -129K -21.29% $1.53 476K Sep 8, 2023 Direct F1
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$4.86K -3.38K -0.71% $1.44 473K Sep 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.